← Eichor
Condition: 68Ga My6349 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: 68Ga My6349

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PET/CT for Trop2 ADC Response Evaluation NSCLC
Phase N/A · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT07151898
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
NA · 1 location(s) · Xijing Hospital · NCT06770478
A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
NA · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06696326
PET/CT for Trop2 ADC Response Evaluation Cancers
Phase N/A · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT07046689
68Ga-MY6349 PET/CT in Solid Tumors
Phase N/A · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT07046702
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.